MedTrace Logo

Evaluation of Dental Bleaching In-office

NCT03192852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-06-29

No results posted yet for this study

Summary

We aim to evaluate colorimetric changes after supervised whitening treatment, using Violet LED light associated or not with carbamide peroxide 35% gel. 80 will be divided into: Group 1 - Violet LED light, Group 2 Violet LED light + carbamide peroxide 35% gel, Group 3 -hydrogen peroxide 35% and Group 4 will be submitted to the gingivoplasty surgery procedure, for aesthetic desire, after whitening treatment with Violet LED light without gel. The colorimetric changes will be measured before, right after each whitening session in the end of the period of 3 months, through the Vitapan Classical (Vita) color scale, and by digital spectrophotometer. The sensibility degree will be measured by the Visual Analogue Scale (VAS) . The gum tissues Group 4, will be analyzed by histomorphometrically. Quality of life will be evaluated.

Conditions

  • Esthetics, Dental

Interventions

OTHER

dental bleaching

dental bleaching can be achieved with light, light+ peroxide carbamide gel, or only with peroxide carbamide gel

PROCEDURE

Gingivoplasty

gengivoplasty will be realized to in illuminated tissue an no illuminated tissue to morphometrically evaluate the tissue

Sponsors & Collaborators

  • University of Nove de Julho

    lead OTHER

Principal Investigators

  • Ana EC Santos, MS · University of Nove de Julho

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-12-20
Completion
2019-12-20

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03192852 on ClinicalTrials.gov